|
|
||||||||
1 Division of Pulmonary and
Critical Care Medicine, Johns Hopkins University School of Medicine,
Baltimore, Maryland 21224;
3 Richard Roudebush Veterans
Affairs Medical Center,
Inflammatory
diseases of the lung are characterized by increases in
vascular permeability and enhanced leukocyte infiltration, reflecting
compromise of the endothelial cell (EC) barrier. We examined potential
molecular mechanisms that underlie these alterations and assessed the
effects of diperoxovanadate (DPV), a potent tyrosine kinase activator
and phosphatase inhibitor, on EC contractile events. Confocal
immunofluorescent microscopy confirmed dramatic increases in
stress-fiber formation and colocalization of EC myosin light chain
(MLC) kinase (MLCK) with the actin cytoskeleton, findings consistent
with activation of the endothelial contractile apparatus. DPV produced
significant time-dependent increases in MLC phosphorylation that were
significantly attenuated but not abolished by EC MLCK inhibition with
KT-5926. Pretreatment with the Rho GTPase-inhibitory C3 exotoxin completely abolished
DPV-induced MLC phosphorylation, consistent with Rho-mediated MLC
phosphatase inhibition and novel regulation of EC MLCK activity.
Immunoprecipitation of EC MLCK after DPV challenge revealed dramatic
time-dependent tyrosine phosphorylation of the kinase in association
with increased MLCK activity and a stable association of MLCK with the
p85 actin-binding protein cortactin and
p60src. Translocation of
immunoreactive cortactin from the cytosol to the cytoskeleton was noted
after DPV in concert with cortactin tyrosine phosphorylation. These
studies indicate that DPV activates the endothelial contractile
apparatus in a Rho GTPase-dependent fashion and suggests that
p60src-induced tyrosine
phosphorylation of MLCK and cortactin may be important features of
contractile complex assembly.
Src kinases; myosin phosphorylation; endothelial cell contraction; permeability
This article has been cited by other articles:
![]() |
A. Chatterjee, C. Snead, G. Yetik-Anacak, G. Antonova, J. Zeng, and J. D. Catravas Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L755 - L763. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Csortos, I. Kolosova, and A. D. Verin Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L843 - L854. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Belik, E. Kerc, and M. D. Pato Rat pulmonary arterial smooth muscle myosin light chain kinase and phosphatase activities decrease with age Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L509 - L516. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mehta and A. B. Malik Signaling Mechanisms Regulating Endothelial Permeability Physiol Rev, January 1, 2006; 86(1): 279 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Usatyuk and V. Natarajan Regulation of reactive oxygen species-induced endothelial cell-cell and cell-matrix contacts by focal adhesion kinase and adherens junction proteins Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L999 - L1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. An, C. M. Pennella, A. Gonnabathula, J. Chen, N. Wang, M. Gaestel, P. M. Hassoun, J. J. Fredberg, and U. S. Kayyali Hypoxia alters biophysical properties of endothelial cells via p38 MAPK- and Rho kinase-dependent pathways Am J Physiol Cell Physiol, September 1, 2005; 289(3): C521 - C530. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tasaka, H. Koh, W. Yamada, M. Shimizu, Y. Ogawa, N. Hasegawa, K. Yamaguchi, Y. Ishii, S. E. Richer, C. M. Doerschuk, et al. Attenuation of Endotoxin-Induced Acute Lung Injury by the Rho-Associated Kinase Inhibitor, Y-27632 Am. J. Respir. Cell Mol. Biol., June 1, 2005; 32(6): 504 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Radel and V. Rizzo Integrin mechanotransduction stimulates caveolin-1 phosphorylation and recruitment of Csk to mediate actin reorganization Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H936 - H945. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mehta, J. Bhattacharya, M. A. Matthay, and A. B. Malik Integrated control of lung fluid balance Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1081 - L1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Harrington, J. Newton, N. Morin, and S. Rounds Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1091 - L1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Nwariaku, P. Rothenbach, Z. Liu, X. Zhu, R. H. Turnage, and L. S. Terada Rho inhibition decreases TNF-induced endothelial MAPK activation and monolayer permeability J Appl Physiol, November 1, 2003; 95(5): 1889 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Usatyuk, V. P. Fomin, S. Shi, J. G. N. Garcia, K. Schaphorst, and V. Natarajan Role of Ca2+ in diperoxovanadate-induced cytoskeletal remodeling and endothelial cell barrier function Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L1006 - L1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. SOMLYO and A. V. SOMLYO Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase Physiol Rev, October 1, 2003; 83(4): 1325 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Birukov, J. R. Jacobson, A. A. Flores, S. Q. Ye, A. A. Birukova, A. D. Verin, and J. G. N. Garcia Magnitude-dependent regulation of pulmonary endothelial cell barrier function by cyclic stretch Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L785 - L797. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Konstantoulaki, P. Kouklis, and A. B. Malik Protein kinase C modifications of VE-cadherin, p120, and {beta}-catenin contribute to endothelial barrier dysregulation induced by thrombin Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L434 - L442. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Qiao, F. Huang, and H. Lum PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L972 - L980. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shikata, K. G. Birukov, and J. G. N. Garcia S1P induces FA remodeling in human pulmonary endothelial cells: role of Rac, GIT1, FAK, and paxillin J Appl Physiol, March 1, 2003; 94(3): 1193 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Gingras, C. Champagne, M. Roy, and J. N. Lavoie Cytoplasmic Death Signal Triggered by Src-Mediated Phosphorylation of the Adenovirus E4orf4 Protein Mol. Cell. Biol., January 1, 2002; 22(1): 41 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wang, A. D. Verin, A. Birukova, L. I. Gilbert-McClain, K. Jacobs, and J. G. N. Garcia Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction: role of MLC phosphorylation Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1472 - L1483. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stevens, R. Rosenberg, W. Aird, T. Quertermous, F. L. Johnson, J. G. N. Garcia, R. P. Hebbel, R. M. Tuder, and S. Garfinkel NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1422 - C1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Dudek and J. G. N. Garcia Cytoskeletal regulation of pulmonary vascular permeability J Appl Physiol, October 1, 2001; 91(4): 1487 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Verin, A. Birukova, P. Wang, F. Liu, P. Becker, K. Birukov, and J. G. N. Garcia Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L565 - L574. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Natarajan, W. M. Scribner, A. J. Morris, S. Roy, S. Vepa, J. Yang, R. Wadgaonkar, S. P. M. Reddy, J. G. N. Garcia, and N. L. Parinandi Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L435 - L449. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Petrache, A. D. Verin, M. T. Crow, A. Birukova, F. Liu, and J. G. N. Garcia Differential effect of MLC kinase in TNF-{alpha}-induced endothelial cell apoptosis and barrier dysfunction Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1168 - L1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Borbiev, A. D. Verin, S. Shi, F. Liu, and J. G. N. Garcia Regulation of endothelial cell barrier function by calcium/calmodulin-dependent protein kinase II Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L983 - L990. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lum and K. A. Roebuck Oxidant stress and endothelial cell dysfunction Am J Physiol Cell Physiol, April 1, 2001; 280(4): C719 - C741. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sandoval, A. B. Malik, T. Naqvi, D. Mehta, and C. Tiruppathi Requirement for Ca2+ signaling in the mechanism of thrombin-induced increase in endothelial permeability Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L239 - L247. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. N. Garcia, K. L. Schaphorst, A. D. Verin, S. Vepa, C. E. Patterson, and V. Natarajan Diperoxovanadate alters endothelial cell focal contacts and barrier function: role of tyrosine phosphorylation J Appl Physiol, December 1, 2000; 89(6): 2333 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Norwood, T. M. Moore, D. A. Dean, R. Bhattacharjee, M. Li, and T. Stevens Store-operated calcium entry and increased endothelial cell permeability Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L815 - L824. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Tinsley, P. De Lanerolle, E. Wilson, W. Ma, and S. Y. Yuan Myosin light chain kinase transference induces myosin light chain activation and endothelial hyperpermeability Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1285 - C1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stevens, J. G. N. Garcia, D. M. Shasby, J. Bhattacharya, and A. B. Malik Mechanisms regulating endothelial cell barrier function Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L419 - L422. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shi, J. G. N. Garcia, S. Roy, N. L. Parinandi, and V. Natarajan Involvement of c-Src in diperoxovanadate-induced endothelial cell barrier dysfunction Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L441 - L451. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Alexander Rho, Tyrosine Kinase, Ca2+, and Junctions in Endothelial Hyperpermeability Circ. Res., August 18, 2000; 87(4): 268 - 271. [Full Text] [PDF] |
||||
![]() |
G. P. v. N. Amerongen, S. v. Delft, M. A. Vermeer, J. G. Collard, and V. W. M. van Hinsbergh Activation of RhoA by Thrombin in Endothelial Hyperpermeability : Role of Rho Kinase and Protein Tyrosine Kinases Circ. Res., August 18, 2000; 87(4): 335 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Verin, F. Liu, N. Bogatcheva, T. Borbiev, M. B. Hershenson, P. Wang, and J. G. N. Garcia Role of Ras-dependent ERK activation in phorbol ester-induced endothelial cell barrier dysfunction Am J Physiol Lung Cell Mol Physiol, August 1, 2000; 279(2): L360 - L370. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |